Published in Eur J Cancer on November 21, 2006
Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst (2010) 4.57
Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol (2009) 3.70
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr (2010) 2.91
Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol (2012) 2.40
The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ. Br J Cancer (2008) 0.95
Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised study. Br J Cancer (2013) 0.85
Relationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ: Analysis of 2996 Women Treated With Breast-conserving Surgery for 30 Years. Ann Surg (2015) 0.85
Web based pathology assessment in RTOG 98-04. J Clin Pathol (2014) 0.84
A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ. Int J Breast Cancer (2013) 0.84
Radiotherapy after conservative surgery in ductal carcinoma in situ of the breast: a review. Int J Surg Oncol (2012) 0.84
The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study. BMC Cancer (2015) 0.82
Predictors for local invasive recurrence of ductal carcinoma in situ of the breast: a meta-analysis. Eur J Cancer Prev (2016) 0.79
Clinical outcomes of ductal carcinoma in situ of the breast treated with partial mastectomy without adjuvant radiotherapy. Yonsei Med J (2012) 0.75
The weakest link. Eur J Cancer (2006) 0.75
Role of the radiotherapy boost on local control in ductal carcinoma in situ. Int J Surg Oncol (2012) 0.75
Co-expression of p16 and p53 characterizes aggressive subtypes of ductal intraepithelial neoplasia. Virchows Arch (2016) 0.75
What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer (1987) 6.20
Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med (1995) 5.85
Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol (1984) 5.36
Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA (1998) 4.65
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost (2006) 4.58
HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped. Lancet (2004) 4.40
High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA (1992) 4.31
The relation between survival and age at diagnosis in breast cancer. N Engl J Med (1986) 4.21
Adverse reactions to nitrofurantoin. Analysis of 921 reports. Am J Med (1980) 4.03
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol (2002) 3.98
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA (1997) 3.80
Patient satisfaction after anaesthesia and surgery: results of a prospective survey of 10,811 patients. Br J Anaesth (2000) 3.46
Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Predicted values, lower limits of normal, and frequencies of abnormality by smoking history. Am Rev Respir Dis (1983) 2.83
Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst (1994) 2.81
Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst (1996) 2.71
10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol (1999) 2.64
The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst (1996) 2.57
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost (2006) 2.56
Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol (1997) 2.46
Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep (1987) 2.37
Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer (2000) 2.34
The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology (1997) 2.29
Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients. Int J Cancer (1987) 2.18
Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status </= 70) and advanced non-small-cell lung cancer. J Clin Oncol (2005) 2.17
Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis. Cytometry (1998) 2.11
Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers. J Clin Oncol (1998) 2.09
Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer. Eur J Surg Oncol (2002) 2.09
Prevalence of disease among vinyl chloride and polyvinyl chloride workers. Ann N Y Acad Sci (1975) 2.04
Significant reduction in advanced breast cancer. Results of the first seven years of mammography screening in Kopparberg, Sweden. Diagn Imaging Clin Med (1985) 2.02
[Problems of interpretation in vascular surgery]. Lakartidningen (1993) 1.94
Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med (1998) 1.91
Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J Natl Cancer Inst (2001) 1.90
Risk of cancer among offspring of childhood-cancer survivors. Association of the Nordic Cancer Registries and the Nordic Society of Paediatric Haematology and Oncology. N Engl J Med (1998) 1.87
Whole-arm t(1;16) and i(1q) as sole anomalies identify gain of 1q as a primary chromosomal abnormality in breast cancer. Genes Chromosomes Cancer (1992) 1.86
A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant (2006) 1.84
Blue babies and nitrate-contaminated well water. Environ Health Perspect (2000) 1.82
Increasing survival trend after cancer diagnosis in Sweden: 1960-1984. J Natl Cancer Inst (1989) 1.82
Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur J Cancer (1997) 1.82
Nationwide cerebrovascular disease morbidity study. Stroke (1972) 1.82
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD). J Thromb Haemost (2008) 1.81
Immediate reconstruction with implants in women with invasive breast cancer does not affect oncological safety in a matched cohort study. Breast Cancer Res Treat (2011) 1.81
HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review. Br J Cancer (2004) 1.79
AHF related protein in clinical praxis. Scand J Haematol (1974) 1.78
Analgesic efficacy of diclofenac in combination with morphine and paracetamol after mastectomy and immediate breast reconstruction. Acta Anaesthesiol Scand (2005) 1.69
Response after withdrawal of tamoxifen and progestogens in advanced breast cancer. Ann Oncol (1992) 1.65
Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology (1992) 1.65
Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome. Ann Oncol (2007) 1.64
Clinical factors associated with the non-utilization of an anaesthesia incident reporting system. Br J Anaesth (2011) 1.61
Undernotification of diagnosed cancer cases to the Stockholm Cancer Registry. Int J Epidemiol (1985) 1.60
Local breast cancer recurrence caused by mammographically guided punctures. Acta Radiol (2000) 1.59
Prognostic factors in mammary carcinoma. Acta Radiol Ther Phys Biol (1976) 1.59
Mammographic screening for breast cancer. What cancers do we find? Eur J Cancer (1997) 1.58
Alterations of the MEN1 gene in sporadic parathyroid tumors. J Clin Endocrinol Metab (1998) 1.58
Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol (2002) 1.58
No association between fat and fatty acids intake and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2001) 1.56
Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial. Lancet (2001) 1.52
Increased cancer risk in offspring of women with colorectal carcinoma: a Swedish register-based cohort study. Cancer (2000) 1.52
Carcinoma of the parotid and submandibular glands--a study of survival in 2465 patients. Oral Oncol (2002) 1.51
Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy. Ann Oncol (1997) 1.51
Body weight and colorectal cancer risk in a cohort of Swedish women: relation varies by age and cancer site. Br J Cancer (2001) 1.49
Florence statement on breast cancer, 1998 forging the way ahead for more research on and better care in breast cancer. Eur J Cancer (1999) 1.48
Venereal transmission of shigellosis in Seattle-King county. Sex Transm Dis (1978) 1.47
The effect of female sex hormones on cancer survival. A register-based study in patients younger than 20 years at diagnosis. JAMA (1990) 1.45
Screening for osteopenia and osteoporosis: selection by body composition. Osteoporos Int (1996) 1.45
The significance of ulcer disease on late mortality after partial gastric resection. Eur J Gastroenterol Hepatol (1997) 1.43
Pulmonary reactions to nitrofurantoin. 447 cases reported to the Swedish Adverse Drug Reaction Committee 1966-1976. Eur J Respir Dis (1981) 1.43
Neuropathologic findings after long-term intrathecal infusion of morphine and bupivacaine for pain treatment in cancer patients. Anesthesiology (1992) 1.43
Risk factors for male breast cancer--a case-control study from Scandinavia. Acta Oncol (2001) 1.40
[Reduced breast cancer mortality. Early treatment, as endocrine and cytostatic adjuvant therapy is effective]. Lakartidningen (1998) 1.39
Intracranial tumors after exposure to ionizing radiation during infancy: a pooled analysis of two Swedish cohorts of 28,008 infants with skin hemangioma. Radiat Res (1998) 1.39
Never on a Saturday (or a Sunday): the case against using weekend urine specimens to assess arsenic exposure. WMJ (1998) 1.38
The role of postoperative alkylating agent therapy in early-stage epithelial ovarian cancer. Br J Obstet Gynaecol (1989) 1.38
Reversed-phase high-performance liquid chromatography: preparative purification of synthetic peptides. J Chromatogr (1984) 1.37
Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci U S A (1990) 1.36
Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients. Br J Cancer (2004) 1.36
Soft tissue sarcoma after treatment for breast cancer--a Swedish population-based study. Eur J Cancer (1998) 1.34
Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer. J Natl Cancer Inst (2000) 1.33
Tumour markers in breast carcinoma correlate with grade rather than with invasiveness. Br J Cancer (2001) 1.33
Cancer incidence after radiotherapy for skin haemangioma during infancy. Acta Oncol (1995) 1.33
The prognostic value of the aspiration biopsy smear in mammary carcinoma. Acta Cytol (1976) 1.32
Purification of urokinase by affinity chromatography. Biochim Biophys Acta (1976) 1.32
Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening. Eur J Cancer (2003) 1.31
Is breast cancer a curable disease? A study of 14,731 women with breast cancer from the Cancer Registry of Norway. Cancer (1984) 1.31
Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics. Eur J Cancer (2001) 1.31
Nurse-protocol management of low back pain. Outcomes, patient satisfaction and efficiency of primary care. West J Med (1975) 1.30
Deep venous thrombosis and occult malignancy: an epidemiological study. BMJ (1994) 1.30
Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid. Scand J Haematol (1965) 1.29
Pulmonary changes among vinyl chloride polymerization workers. Chest (1976) 1.27
Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer (2000) 1.26
Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancer. Cancer (1987) 1.26
Health advisories for consumers of Great Lakes sport fish: is the message being received? Environ Health Perspect (1997) 1.26